The tobacco industry is going smoke-free

Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Companies in the news and how they were assessed

Rich pickings: Many in the City of London are fretting about the lack of inward investment, but if there is one financial British product North Americans cannot get enough of it’s pensions, says Liam

CITY